Although CD68 has been commonly used as a pan-macrophage marker (48, 49), it is now accepted that macrophages – especially tumor-associated macrophages (TAM) – exist on a vast phenotypic and functional gradient, from anti-tumor-polarized M1 to pro-tumor M2 macrophages (50–52). This evidence concerns the gene CD68 and neoplasm.